The Centers for Disease Control and Prevention (CDC) officially recommended the first preventive Respiratory syncytial virus (RSV) treatment for infants on Thursday, shortly after a key panel endorsed the product. CDC Director Mandy Cohen adopted the guidance recommended by the Advisory Committee on Immunization Practices (ACIP) on Thursday for the administration of nirsevimab, or Beyfortus. The treatment has been recommended for infants under eight months old who are born during or are entering their first RSV season as well as infants between eight and 19 months who are at an increased risk of severe illness and are entering their second RSV season. It is administered with one in
Hence then, the article about cdc recommends preventive rsv antibody for infants was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( CDC recommends preventive RSV antibody for infants )